Harsh Vardhan orders replacement of AIIMS Trauma Centre chief after COVID-19 positive journalist's death
A four-member inquiry committee, constituted to examine the journalist's death, found no lapses in the COVID-19 treatment protocol
New Delhi: Union Health Minister Dr Harsh Vardhan on Friday ordered an immediate replacement of Medical Superintendent of AIIMS Jai Prakash Narayan Apex Trauma Center (JPNATC).
The directive has come in the backdrop of the recent incident when a COVID-19 positive journalist patient jumped from the 4th floor of the trauma centre and died.
"Ordered immediate replacement of Medical Superintendent of AIIMS Trauma Centre JPNATC. On 6 July, a COVID-19 positive journalist patient Shri Tarun Sisodiya had jumped from the fourth floor and died," Vardhan tweeted.
Earlier he said that he directed that an expert committee be constituted to suggest suitable changes in administration, for AIIMS as well as JPNATC. "The report, along with its recommendations, shall be submitted before me by 27 July, 2020," he tweeted.
The four-member inquiry committee, constituted to examine the suicide, did not find any malafide intent in the death of the journalist.
The 4-member inquiry committee, constituted to examine the suicide of Shri Tarun Sisodiya, had submitted its report today.
The committee did not find any malafide intent in the death of Mr Sisodiya. It also did not find any lapses in the treatment protocol of #Covid19 .
— Dr Harsh Vardhan (@drharshvardhan) July 10, 2020
The top court noted that the NMC has issued an advisory in April, asking universities to take the COVID-19 situation into consideration while announcing exam dates
Delta variant of COVID-19 can infect despite Covishield, Covaxin doses, claims preliminary AIIMS study
The study included 63 people who got breakthrough infections; of which 36 patients received two doses, while 27 had received one dose of vaccine
Seroprevalence higher in girls, but third COVID wave unlikely to affect children more, finds AIIMS serosurvey
The study, which compared the COVID-19 sero-positivity rate between children and adults in four states found a seroprevalence of 55.7 percent in those aged less than 18 (two to 17 years) age group and 63.5 percent in the 18 years and above age group